November 2022 Editor’s Choice: Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?
- Author
- Health Advance
- Published
- Thu 03 Nov 2022
- Episode Link
- https://www.clinicalimaging.org/pb-assets/Health%20Advance/journals/ygyno/podcasts/1122_FaderGershensonGourley2.mp3
Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology
Featuring:
David M. Gershenson, MD, The University of Texas MD Anderson Cancer Center
Charlie Gourley, MD, Nicola Murray Centre for Ovarian Cancer Research
Editor’s Choice Paper: Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival
Editorial: Low grade serous ovarian cancer: Unpicking drivers of outcome
